Rapid diagnosis. More answers. Better patient outcomes.
Rapid diagnosis—with more information per test—is the key to directing appropriate therapy. The result? Better patient outcomes. With this objective in mind, Great Basin Corporation is delivering the right next step in molecular diagnostics, providing several key advantages over other molecular solutions:
- Multiplexes up to 64 distinct targets in a single assay for more answers
- Rapid results in less than an hour depending on the target of interest
- On-demand testing; no batching of tests that delays results
- Fully automated with no more than two-to-three hands-on steps
We’re committed to giving healthcare providers and their patients the benefit of rapid, information-rich point-of-care test results at a fraction of the cost of other molecular diagnostic solutions.